Elanco CEO awarded 115 deferred stock units

Elanco Animal Health Inc reported that President and CEO Jeffrey N. Simmons received a grant of deferred stock units under a compensation plan.

Rhea-AI Filing Summary

Elanco Animal Health Inc reported that President and CEO Jeffrey N. Simmons received a grant of deferred stock units under a compensation plan. The award covers 115.0562 deferred stock units, each linked to one share of Elanco common stock or its cash equivalent at a reference value of $24.57 per unit.

Following this award, Simmons holds a total of 24,657.0048 deferred stock units directly. These units are designed to settle in cash or company shares after his employment ends or in a specified future year, in line with the Executive Deferral and Stock Match Plan, making this a routine, non-market, compensation-related acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 115.0562 shares

Grant/Award 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	115.0562	$24.57	$3K

Holdings After Transaction: Deferred Stock Units — 24,657.0048 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 115.0562 units Reported value per unit: $24.57 per unit Deferred stock units after grant: 24,657.0048 units +1 more

4 metrics

Deferred stock units granted 115.0562 units Grant to CEO on June 26, 2026

Reported value per unit $24.57 per unit Reference price for deferred stock units

Deferred stock units after grant 24,657.0048 units CEO’s total direct deferred stock units post-transaction

Conversion price $0.00 Conversion or exercise price for deferred stock units

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, Form 4

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."

Form 4 regulatory

"This compensation-related acquisition was reported on a Form 4 insider trading report."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Elanco (ELAN) report for CEO Jeffrey Simmons?

Elanco reported that CEO Jeffrey Simmons received 115.0562 deferred stock units as a compensation-related grant. Each unit tracks one share of common stock or its cash equivalent, settling in the future under the Executive Deferral and Stock Match Plan, not through an immediate market trade.

How many deferred stock units does the Elanco (ELAN) CEO hold after this Form 4?

After this grant, Jeffrey Simmons holds 24,657.0048 deferred stock units directly. These units represent future rights tied to Elanco common stock or cash, and they are scheduled to settle after employment ends or in a designated future year under the company’s deferral plan.

Was the Elanco (ELAN) CEO’s Form 4 transaction a market purchase or sale?

The transaction was not a market purchase or sale. It was an acquisition coded “A,” meaning a grant or award of 115.0562 deferred stock units as part of compensation, with no open-market buying or selling involved in this particular Form 4 filing.

At what reference price were Elanco (ELAN) deferred stock units granted to the CEO?

The 115.0562 deferred stock units were reported with a value of $24.57 per unit. This figure reflects the price per underlying share used for reporting purposes on the Form 4 and helps quantify the size of the compensation-related award to the CEO.

When will the Elanco (ELAN) CEO’s deferred stock units from this grant settle?

The deferred stock units are set to settle in cash or Elanco common shares after the CEO’s employment terminates or during a specified future year. Settlement timing follows the terms of Elanco’s Executive Deferral and Stock Match Plan described in the Form 4 footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 04:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	06/26/2026		A		115.0562		(2)	(2)	Common Stock	115.0562	$24.57	24,657.0048	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)